Bangwei Cao

2.9k total citations
94 papers, 1.9k citations indexed

About

Bangwei Cao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bangwei Cao has authored 94 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 32 papers in Molecular Biology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bangwei Cao's work include Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Bangwei Cao is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Bangwei Cao collaborates with scholars based in China, United States and Macao. Bangwei Cao's co-authors include Lei Zhao, Juanjuan Che, Wenting Liu, Jing Xiao, Junxian Yu, Qin Li, Kun Shang, Jing Yu, Haishan Lin and Yingjie Ma and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Bangwei Cao

90 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bangwei Cao China 25 860 624 482 325 277 94 1.9k
Jingdong Zhang China 23 689 0.8× 629 1.0× 373 0.8× 352 1.1× 164 0.6× 118 1.7k
Li Zhu China 26 553 0.6× 792 1.3× 634 1.3× 373 1.1× 262 0.9× 124 2.0k
Pu Xia China 21 892 1.0× 522 0.8× 461 1.0× 297 0.9× 133 0.5× 74 1.6k
Ke Yang China 26 1.0k 1.2× 405 0.6× 394 0.8× 247 0.8× 326 1.2× 84 2.1k
Chaoliu Dai China 17 870 1.0× 627 1.0× 453 0.9× 248 0.8× 363 1.3× 44 1.8k
Suimin Qiu United States 26 1.0k 1.2× 942 1.5× 428 0.9× 234 0.7× 389 1.4× 91 2.5k
Chunxiao Liu China 27 1.4k 1.6× 487 0.8× 635 1.3× 365 1.1× 242 0.9× 136 2.3k
Meng Xia China 26 1.3k 1.5× 397 0.6× 507 1.1× 172 0.5× 314 1.1× 93 2.3k
Xinchen Sun China 28 1.2k 1.4× 706 1.1× 577 1.2× 509 1.6× 163 0.6× 133 2.3k

Countries citing papers authored by Bangwei Cao

Since Specialization
Citations

This map shows the geographic impact of Bangwei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangwei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangwei Cao more than expected).

Fields of papers citing papers by Bangwei Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bangwei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangwei Cao. The network helps show where Bangwei Cao may publish in the future.

Co-authorship network of co-authors of Bangwei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Bangwei Cao. A scholar is included among the top collaborators of Bangwei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangwei Cao. Bangwei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingting, et al.. (2024). Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors. BMC Immunology. 25(1). 8–8. 34 indexed citations
2.
Lin, Haishan & Bangwei Cao. (2024). Circulating VEGF and inflammatory bowel disease: a bidirectional mendelian randomization. Frontiers in Genetics. 15. 1282471–1282471. 2 indexed citations
3.
Lin, Haishan & Bangwei Cao. (2024). Severe COVID-19 and chronic kidney disease: bidirectional mendelian randomization study. Virology Journal. 21(1). 32–32. 3 indexed citations
4.
5.
Yan, Kang, et al.. (2023). Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology. 149(17). 16239–16246.
6.
7.
Wang, Yusheng, et al.. (2021). Efficacy and safety of sintilimab-based regimens against advanced gastric and gastroesophageal junction adenocarcinoma. Journal of Cancer Research and Therapeutics. 17(5). 1234–1240. 5 indexed citations
8.
Che, Juanjuan, Jing Wang, Huihui Li, et al.. (2021). Decreased expression of Dlg5 is associated with a poor prognosis and epithelial–mesenchymal transition in squamous cell lung cancer. Journal of Thoracic Disease. 13(5). 3115–3125. 10 indexed citations
9.
Zheng, Xixi, Juan Liu, Xiao Li, et al.. (2020). Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells. Cancer Letters. 497. 190–201. 41 indexed citations
10.
Zhao, Lei, Kun Shang, Fang Liu, et al.. (2020). Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer. Molecular Medicine. 26(1). 30–30. 32 indexed citations
11.
Su, Qiang, Xiao‐Chen Zhang, Chenguang Zhang, et al.. (2018). Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis. Journal of Immunology Research. 2018. 1–9. 44 indexed citations
12.
Lin, Haishan, Guowei Yang, Jing Yu, et al.. (2018). KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1. Biomedicine & Pharmacotherapy. 107. 1205–1209. 30 indexed citations
13.
14.
Wu, Jun, Junxian Yu, Jing Wang, et al.. (2018). Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway. Biomedicine & Pharmacotherapy. 100. 176–183. 62 indexed citations
15.
Geng, Fang, Zheng Wang, Hang Yin, Junxian Yu, & Bangwei Cao. (2017). Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives. Cancer Biotherapy and Radiopharmaceuticals. 32(5). 149–160. 88 indexed citations
16.
Xu, Anjian, et al.. (2017). Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells. Annals of Oncology. 28. v12–v12. 3 indexed citations
17.
Zhao, Lei, Jing Wang, Huihui Li, et al.. (2017). Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer. BMC Pulmonary Medicine. 17(1). 112–112. 50 indexed citations
18.
Yu, Jing, Juanjuan Che, Lian Liu, et al.. (2016). Tetrahydropalmatine attenuates irradiation induced lung injuries in rats. Life Sciences. 153. 74–81. 22 indexed citations
19.
Li, Qin, Yan Han, Pengfei Zhao, Yifan Yang, & Bangwei Cao. (2015). Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials. Scientific Reports. 5(1). 15746–15746. 29 indexed citations
20.
Zhao, Lei, Wenting Liu, Jing Xiao, & Bangwei Cao. (2014). The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance. Cancer Letters. 356(2). 339–346. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingdong Zhang Breakdown of academic impact, for papers by Li Zhu Breakdown of academic impact, for papers by Pu Xia Breakdown of academic impact, for papers by Ke Yang Breakdown of academic impact, for papers by Chaoliu Dai Breakdown of academic impact, for papers by Suimin Qiu Breakdown of academic impact, for papers by Chunxiao Liu Breakdown of academic impact, for papers by Meng Xia Breakdown of academic impact, for papers by Xinchen Sun
Rankless by CCL
2026